Patents-Review.com
ClassID:

94428 ⎘

C07D233/80 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms

Sub-classes:
Recent Application in this class:
#1
20250359552
2025-11-27

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

 #2
20250313539
2025-10-09

Alpha, Beta-UNSATURATED AMIDE COMPOUND, AND PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

 #3
20250134105
2025-05-01

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

 #4
20250008960
2025-01-09

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

 #5
20230180761
2023-06-15

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #6
20220380325
2022-12-01

ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE

 #7
20210008085
2021-01-14

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

 #8
20210000846
2021-01-07

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

 #9
20200247763
2020-08-06

Androgen receptor modulators and methods for their use

 #10
20200246360
2020-08-06

Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

 #11
20200196607
2020-06-25

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #12
20190330210
2019-10-31

Hydantoin containing deoxyuridine triphosphatase inhibitors

 #13
20190255021
2019-08-22

Treatment using dantrolene

 #14
20190090488
2019-03-28

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #15
20180282288
2018-10-04

Lp-PLA2 inhibitors

 #16
20180125822
2018-05-10

Treatment using dantrolene

 #17
20180065935
2018-03-08

Polymers functionalized with N-protected hydantoin compounds

 #18
20180007911
2018-01-11

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #19
20180000087
2018-01-04

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #20
20170339961
2017-11-30

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #21
20170216326
2017-08-03

Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

 #22
20160340318
2016-11-24

2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators

 #23
20160332972
2016-11-17

Urea hydantoin derivatives as formyl peptide modulators

 #24
20160304522
2016-10-20

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #25
20160302418
2016-10-20

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #26
20160302417
2016-10-20

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #27
20160243083
2016-08-25

Treatment using dantrolene

 #28
20160074366
2016-03-17

Treatment using dantrolene

 #29
20150191417
2015-07-09

Anti-proliferative compounds and uses thereof

 #30
20150080364
2015-03-19

Carbamate compounds and of making and using same

 #31
20150057236
2015-02-26

Modulators for Sirt5 and assays for screening same

 #32
20140256685
2014-09-11

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

 #33
20140099382
2014-04-10

Treatment using dantrolene

 #34
20140039020
2014-02-06

Oligomer-containing hydantoin compounds

 #35
20120121663
2012-05-17

Treatment using dantrolene

 #36
20120121662
2012-05-17

Treatment using dantrolene

 #37
20100174092
2010-07-08

5 substituted hydantoins

 #38
20100160400
2010-06-24

Treatment using dantrolene

 #39
20100137349
2010-06-03

Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions

 #40
20100087442
2010-04-08

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

 #41
20090274947
2009-11-05

Imidazolidinone nitroxides as electrode materials for energy storage devices

 #42
20090099243
2009-04-16

ORGANIC COMPOUNDS

 #43
20070238700
2007-10-11

N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES

 #44
20060111303
2006-05-25

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

 #45
18492713
2024-05-07

1-(2-hydroxybenzylideneamino)-5-phenylimidazolidine-2,4-dione as an antimicrobial compound

 #46
18488967
2024-02-20

1-(3-chlorobenzylideneamino)-5,5-diphenylimidazolidine-2,4-dione as an antimicrobial compound

 #47
18430527
2024-06-04

1-(2-hydroxybenzylideneamino)-5-phenylimidazolidine-2,4-dione as an antimicrobial compound

 #48
18400944
2024-05-28

Ethyl [4,4-bis(4-bromophenyl)-2,5-dioxoimidazolidin-1-yl]acetate as an antimicrobial compound

 #49
18382819
2024-03-12

1-(2-chlorobenzylideneamino)-5,5-diphenylimidazolidine-2,4-dione as an antimicrobial compound

 #50
18382696
2024-03-12

1-(4-nitrobenzylideneamino)-5-phenylimidazolidine-2,4-dione as an antimicrobial compound